Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging

Acta Psychiatrica Scandinavica

Volumn 86, Issue 6, 1992, Pages 455-462

  Fujimoto, T ^a   Nakano, T ^a   Takano, T ^a   Hokazono, Y ^a   Asakura, T ^b   Tsuji, T ^c  

^a Fujimoto Hospital ^*  (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

chemical shift imaging; magnetic resonance; schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; PHOSPHODIESTER; PHOSPHORUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION; BRAIN DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA; TEMPORAL LOBE;

ADENOSINE TRIPHOSPHATE; BASAL GANGLIA; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; CHRONIC DISEASE; CORPUS CALLOSUM; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DOMINANCE, CEREBRAL; ENERGY METABOLISM; HUMAN; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE LIPIDS; PHOSPHATES; PHOSPHOLIPIDS; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0026469246     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1992.tb03297.x     Document Type: Article

References (33)

1. 31P NMR.
2. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe
3. Alterations in brain high‐energy phosphate and membrane phospholipid metabolism in first‐episode, drug‐naive schizophrenics
4. 31P‐CSI.
5. 31P spectroscopic imaging in the human brain.
6. The positive and negative syndrome scale (PANSS) for schizophrenia
7. 1H MRI at 1.5 and 2.0 T.
8. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations.
9. 31P in vivo spectroscopy of adult human brain
10. 31P NMR detection of mobile dog brain phospholipids.
11. 31P NMR spectra in vivo.
12. 31P NMR spectroscopy.
13. Phospholipid and prostaglandin hypotheses of schizophrenia.
14. Molecular insights into Alzheimer's disease
15. 2 dopamine receptors in drug‐naive schizophrenics.
16. 1 in dog brains due to the administration of haloperidol.
17. 2 relaxation times in rat brain and in rat brain tumors implanted to nude mice.
18. Sight and insight: regional cerebral metabolic activity in schizophrenia visualised by positron emission tomography, and competing neurodevelopmental perspectives
19. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia
20. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression
21. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia
22. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration
23. Cerebral hemisphere asymmetries and interhemispheric integration in schizophrenia.
24. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study
25. Temporal lobe asymmetry in schizophrenics by coronal MRI
26. Postmortem evidence of structural brain changes in schizophrenia
27. Basal ganglia and limbic system pathology in schizophrenia